These findings suggest elevated levels of CEA, CA19-9, and CA125 are associated with overall survival in appendiceal adenocarcinoma, highlighting the importance of including all 3 biomarkers in the initial workup of patients with this disease. This evidence concerns the gene CEACAM5 and appendix adenocarcinoma.